Cargando…
Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates
Intragenic deletion is the most common form of activating mutation among receptor tyrosine kinases (RTK) in glioblastoma. However, these events are not detected by conventional DNA sequencing methods commonly utilized for tumor genotyping. To comprehensively assess the frequency, distribution, and e...
Autores principales: | Kastenhuber, Edward R., Huse, Jason T., Berman, Samuel H., Pedraza, Alicia, Zhang, Jianan, Suehara, Yoshiyuki, Viale, Agnes, Cavatore, Magali, Heguy, Adriana, Szerlip, Nicholas, Ladanyi, Marc, Brennan, Cameron W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984672/ https://www.ncbi.nlm.nih.gov/pubmed/24292886 http://dx.doi.org/10.1007/s00401-013-1217-3 |
Ejemplares similares
-
A birth of bipartite exon by intragenic deletion
por: Nozu, Kandai, et al.
Publicado: (2017) -
Early neuroimaging markers of FOXP2 intragenic deletion
por: Liégeois, Frédérique J., et al.
Publicado: (2016) -
Intragenic breakpoint: A marker of genome instability in glioblastoma
por: Zheng, Siyuan, et al.
Publicado: (2013) -
Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome
por: van Reeuwijk, Jeroen, et al.
Publicado: (2007) -
Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
por: Kannan, Kasthuri, et al.
Publicado: (2012)